69 – Inherited Genetic Susceptibility and Breast Cancer

作者: BETH NEWMAN

DOI: 10.1016/B978-012288145-9/50080-2

关键词: Breast cancerFamily historyDiseaseGenetic predispositionFamily aggregationInternal medicineGynecologyMedicineOffspringCancerPopulationOncology

摘要: Most diseases, including breast cancer, require a number of factors before they occur. Breast cancer is thought to arise from series genetic alterations that accumulate in cell during woman's (or man's) life. Some these may be inherited at conception and, therefore, appear virtually all cells the body, but most occur specifically cell(s) later Depending on particular genes and mutations involved, whether are repaired or otherwise corrected, only one both copies gene affected, escape its usual controls become cancer. When more passed down parent offspring over generations, families experience many cases among their members. A systematic investigation causes mortality confirmed family history disease was best predictors; women who died were likely than others have members had been diagnosed with as well. That far science got understanding familial aggregation for several decades, although numerous epidemiologic studies addressed issue increasing sophistication, substituting incidence data data, moving clinical populations general population, analyzing premenopausal postmenopausal separately.

参考文章(101)
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
C. Kent Osborne, Richard M. Elledge, Powel H. Brown, Susan G. Hilsenbeck, BRCA1 in Clinical Breast Cancer Breast disease. ,vol. 10, pp. 77- 88 ,(1998) , 10.3233/BD-1998-101-210
C I Szabo, M C King, Population genetics of BRCA1 and BRCA2. American Journal of Human Genetics. ,vol. 60, pp. 1013- 1020 ,(1997)
S Narod, D Goldgar, J Eyfjord, D Easton, G Lenoir, O Serova, P Devilee, D Ford, R B Barkardottir, Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 57, pp. 957- 958 ,(1995)
Jeffery P. Struewing, BRCA1 in special populations. Breast disease. ,vol. 10, pp. 71- 75 ,(1998) , 10.3233/BD-1998-101-209
Elizabeth L. Schubert, Jamie L. Dann, Jan E. Morrow, Mary Claire King, Ming K. Lee, Judy Hull, Rhodora H. Argonza, Heather C. Mefford, BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2 American Journal of Human Genetics. ,vol. 60, pp. 1031- 1040 ,(1997)
Steven A. Narod, Gilbert M. Lenoir, David Goldgar, Patricia Tonin, Sylvie Mazoyer, Yin Y. Shugart, Henry T. Lynch, Nadine Puget, Olga M. Serova, Valérie Dubois, Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? American Journal of Human Genetics. ,vol. 60, pp. 486- 495 ,(1997)
Laurence N. Kolonel, Brian E. Henderson, Gerhard A. Coetzee, Ronald K. Ross, Heather Spencer Feigelson, A Polymorphism in the CYP17 Gene Increases the Risk of Breast Cancer Cancer Research. ,vol. 57, pp. 1063- 1065 ,(1997)
M. Dreyfus, S. H. Friend, J. E. Garber, T. Frebourg, J. Fraumeni, N. Barbier, Yu-Xin Yan, F. P. Li, Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. American Journal of Human Genetics. ,vol. 56, pp. 608- 615 ,(1995)
T. Kurosaki, B. Noble, H. Anton-Culver, D. Gordon, L. S. Friedman, B. A. J. Ponder, G. Casey, S. A. Gayther, Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population American Journal of Human Genetics. ,vol. 60, pp. 313- 319 ,(1997)